Aetna Inc. (AET) to Post Q4 2017 Earnings of $1.26 Per Share, Leerink Swann Forecasts
Aetna Inc. (NYSE:AET) – Equities research analysts at Leerink Swann decreased their Q4 2017 EPS estimates for shares of Aetna in a research note issued on Monday. Leerink Swann analyst A. Gupte now anticipates that the company will earn $1.26 per share for the quarter, down from their previous forecast of $1.67. Leerink Swann also issued estimates for Aetna’s FY2019 earnings at $11.37 EPS and FY2020 earnings at $12.78 EPS.
Several other equities research analysts also recently weighed in on AET. UBS AG reaffirmed a “buy” rating and issued a $160.00 price objective (up previously from $147.00) on shares of Aetna in a report on Wednesday, May 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $175.00 price objective (up previously from $150.00) on shares of Aetna in a report on Wednesday, August 9th. Deutsche Bank AG upped their price objective on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a report on Monday, August 7th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $163.00 price objective (up previously from $157.00) on shares of Aetna in a report on Friday, August 4th. Finally, Royal Bank Of Canada upped their price objective on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a report on Friday, August 4th. Eight equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. Aetna has a consensus rating of “Buy” and an average price target of $157.09.
TRADEMARK VIOLATION NOTICE: “Aetna Inc. (AET) to Post Q4 2017 Earnings of $1.26 Per Share, Leerink Swann Forecasts” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.americanbankingnews.com/2017/08/16/aetna-inc-aet-to-post-q4-2017-earnings-of-1-26-per-share-leerink-swann-forecasts.html.
Shares of Aetna (NYSE AET) traded up 0.51% during mid-day trading on Wednesday, hitting $156.56. 232,478 shares of the company traded hands. The firm has a 50-day moving average price of $154.49 and a 200 day moving average price of $139.88. The firm has a market cap of $51.99 billion, a price-to-earnings ratio of 34.75 and a beta of 0.54. Aetna has a 52-week low of $104.59 and a 52-week high of $161.69.
Aetna (NYSE:AET) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The firm had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. During the same quarter last year, the business earned $2.21 earnings per share. The business’s revenue for the quarter was down 2.7% compared to the same quarter last year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Thursday, July 13th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date was Tuesday, July 11th. Aetna’s dividend payout ratio is presently 43.67%.
In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of the company’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,008,606.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.14% of the stock is currently owned by corporate insiders.
Several institutional investors have recently modified their holdings of the stock. Guardian Life Insurance Co. of America increased its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares in the last quarter. Concert Wealth Management Inc. increased its position in shares of Aetna by 0.4% in the first quarter. Concert Wealth Management Inc. now owns 3,262 shares of the company’s stock worth $405,000 after buying an additional 14 shares in the last quarter. CAPROCK Group Inc. increased its position in shares of Aetna by 0.9% in the first quarter. CAPROCK Group Inc. now owns 2,824 shares of the company’s stock worth $360,000 after buying an additional 25 shares in the last quarter. Rehmann Capital Advisory Group increased its position in shares of Aetna by 1.1% in the first quarter. Rehmann Capital Advisory Group now owns 2,335 shares of the company’s stock worth $298,000 after buying an additional 25 shares in the last quarter. Finally, Geneva Advisors LLC increased its position in shares of Aetna by 1.0% in the first quarter. Geneva Advisors LLC now owns 2,588 shares of the company’s stock worth $330,000 after buying an additional 25 shares in the last quarter. Institutional investors own 91.69% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.